Drug Shortage Report for TEVA-FUROSEMIDE
| Report ID | 218940 |
| Drug Identification Number | 00337749 |
| Brand name | TEVA-FUROSEMIDE |
| Common or Proper name | FUROSEMIDE 40MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | FUROSEMIDE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100's |
| ATC code | C03CA |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-07 |
| Estimated end date | 2025-02-10 |
| Actual end date | 2025-01-29 |
| Shortage status | Resolved |
| Updated date | 2025-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v43 | 2025-01-30 | French | Compare |
| v42 | 2025-01-30 | English | Compare |
| v41 | 2025-01-16 | French | Compare |
| v40 | 2025-01-16 | English | Compare |
| v39 | 2024-12-19 | French | Compare |
| v38 | 2024-12-19 | English | Compare |
| v37 | 2024-12-13 | French | Compare |
| v36 | 2024-12-13 | English | Compare |
| v35 | 2024-11-28 | French | Compare |
| v34 | 2024-11-28 | English | Compare |
| v33 | 2024-11-21 | French | Compare |
| v32 | 2024-11-21 | English | Compare |
| v31 | 2024-11-14 | French | Compare |
| v30 | 2024-11-14 | English | Compare |
| v29 | 2024-11-14 | French | Compare |
| v28 | 2024-11-14 | English | Compare |
| v27 | 2024-10-24 | French | Compare |
| v26 | 2024-10-24 | English | Compare |
| v25 | 2024-10-17 | French | Compare |
| v24 | 2024-10-17 | English | Compare |